Allievex Completes Series A Financing Led by Pappas Capital and Novo Holdings

From PR Newswire: Allievex Corporation ("Allievex"), a clinical-stage biotechnology company founded by Pappas Capital, today announced the completion of a Series A financing co-led by Novo Holdings and Pappas Capital. Allievex has also appointed Kyle Rasbach, Ph.D., PharmD., Managing Partner at Pappas Ventures and Tiba Aynechi, Ph.D., Partner at Novo Holdings, to its Board of Directors. Read the full press release here.

Related Posts

See All
Screen Shot 2021-01-25 at 4.58.05 PM.png

CONNECT

Allievex Corporation

P.O. Box 1056

Marblehead, MA 01945

USA